A natural product telomerase activator as part of a health maintenance program

Rejuvenation Research

Volumn 14, Issue 1, 2011, Pages 45-56

  Harley, Calvin B ^a,f   Liu, Weimin ^b   Blasco, Maria ^c   Vera, Elsa ^c   Andrews, William H ^d   Briggs, Laura A ^d   Raffaele, Joseph M ^e  

^a GERON CORPORATION   (United States)

^b TA Sciences   (United States)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

^d Sierra Sciences   (United States)

^e PhysioAge Systems   (United States)

^f Telome Health Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME ACTIVATOR; HERBACEOUS AGENT; TA 65; TELOMERASE; TELOMERASE ACTIVATOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; DRUG EFFECT; FEMALE; FIBROBLAST; HEALTH MAINTENANCE PROGRAM; HEALTH PROGRAM; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; KERATINOCYTE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; TELOMERE;

BIOLOGICAL PRODUCTS; CELL COUNT; CELLS, CULTURED; CYTOMEGALOVIRUS; ENZYME ACTIVATORS; FEMALE; FETUS; FIBROBLASTS; HEALTH; HUMANS; IMMUNE SYSTEM; INFANT, NEWBORN; KERATINOCYTES; MALE; MIDDLE AGED; TELOMERASE; TELOMERE; TIME FACTORS;

CYTOMEGALOVIRUS;

EID: 78650973371     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2010.1085     Document Type: Article

References (65)

1. Marik PE, Varon J. Omega-3 dietary supplements and the risk of cardiovascular events: A systematic review. Clin Cardiol 2009;32:365-372.
2. Khandanpour N, Armon MP, Jennings B, Finglas PM, Willis G, Clark A, Meyer FJ. Randomized clinical trial of folate supplementation in patients with peripheral arterial disease. Br J Surg 2009;96:990-998.
3. Bemis DL, Katz AE, Buttyan R. Clinical trials of natural products as chemopreventive agents for prostate cancer. Expert Opin Investig Drugs 2006;15:1191-1200. (Pubitemid 44608259)
4. Iannitti T, Palmieri B. Antioxidant therapy effectiveness: an up to date. Eur Rev Med Pharmacol Sci 2009;13:245-278.
5. Judd SE, Tangpricha V. Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci 2009;338:40-44.
6. Nigwekar SU, Kandula P. N-acetylcysteine in cardiovascular-surgery- associated renal failure: A meta-analysis. Ann Thorac Surg 2009;87:139-147.
7. Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging. Nat Med 2006;12:1133-1138. (Pubitemid 44527346)
8. Harley CB. Telomerase therapeutics for degenerative diseases. Curr Mol Med 2005;5:205-211. (Pubitemid 40601648)
9. Ayouaz A, Raynaud C, Heride C, Revaud D, Sabatier L. Telomeres: Hallmarks of radiosensitivity. Biochimie 2008;90: 60-72. (Pubitemid 350216220)
10. Wright DL, Jones E, Mayer J, Oehninger S, Gibbons W, Lanzendorf SE. Characterization of telomerase activity in the human oocyte and preimplantation embryo. Mol Hum Re-prod 2001;7:947-955. (Pubitemid 32952176)
11. Ulaner GA, Giudice LC. Developmental regulation of telo-merase activity in human fetal tissues during gestation. Mol Hum Reprod 1997;3:769-773. (Pubitemid 127509610)
12. Harley CB. Telomerase is not an oncogene. Oncogene 2002;21:494-502. (Pubitemid 34146249)
13. Flores I, Benetti R, Blasco MA. Telomerase regulation and stem cell behaviour. Curr Opin Cell Biol 2006;18:254-260.
14. Effros RB. Telomerase induction in T cells: A cure for aging and disease? Gerontol 2007;42:416-420. (Pubitemid 46578280)
15. Effros RB. Genetic alterations in the ageing immune system: Impact on infection and cancer. Mech Ageing Dev 2003; 124:71-77. (Pubitemid 36262900)
16. Epel ES. Psychological and metabolic stress: a recipe for accelerated cellular aging? Hormones (Athens) 2009;8:7-22.
17. Von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci 2002;27:339-344. (Pubitemid 34756516)
18. Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, Cawthon RM. Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 2004;101: 17312-17315. (Pubitemid 39627816)
19. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 1990;345:458-460.
20. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990;346:866-868.
21. Garcia CK, Wright WE, Shay JW. Human diseases of telo-merase dysfunction: insights into Tissue aging. Nucleic Acids Res 2007;35:7406-7416.
22. Armanios MY, Chenn JJ, Cogan JD, Alder JK, Ingersoll RG, Markin C, Lawson WE, Xie M, Vulto I, Phillips JAr, Lans-dorp PM, Greider CW, Loyd JE. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007;356:1370-1372.
23. Sebastian C, Herrero C, Serra M, Lloberas J, Blasco MA, Celada A. Telomere shortening and oxidative stress in aged macrophages results in impaired STAT5a phosphorylation. J Immunol 2009;183:2356-2364.
24. Calado RT. Telomeres and marrow failure. Hematology Am Soc Hematol Educ Program 2009:338-343.
25. Calado RT, Young NS. Telomere diseases. N Engl J Med 2009;361:2353-2365.
26. Rajaraman S, Choi J, Cheung P, Beaudry V, Moore H, Ar-tandi SE. Telomere uncapping in progenitor cells with critical telomere shortening is coupled to S-phase progression in vivo. Proc Natl Acad Sci USA 2007;104:17747-17752. (Pubitemid 350210906)
27. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003;361:359-395.
28. Savage SA, Alter BP. The role of telomere biology in bone marrow failure and other disorders. Mech Ageing Dev 2008;129:35-47.
29. Aviv A, Valdes A, Gardner JP, Swaminathan R, Kimura M, Spector TD. Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation. J Clin Endocrinol Metab 2006;91:635-640. (Pubitemid 43236936)
30. Lukens JN, Van Deerlin V, Clark CM, Xie SX, Johnson FB. Comparisons of telomere lengths in peripheral blood and cerebellum in Alzheimer's disease. Alzheimers Dement 2009;5:463-469.
31. Weyand CM, Fujii H, Shao L, Goronzy JJ. Rejuvenating the immune system in rheumatoid arthritis. Nat Rev Rheumatol 2009;5:583-588.
32. Spyridopoulos I, Hoffmann J, Aicher A, Brummendorf TH, Doerr HW, Zeiher AM, Dimmeler S. Accelerated telomere shortening in leukocyte subpopulations of patients with coronary heart disease: role of cytomegalovirus seroposi-tivity. Circulation 2009;120:1364-1372.
33. Effros RB. Telomerase induction in T cells: A cure for aging and disease? Exp Gerontol 2007;42:416-420. (Pubitemid 46578280)
34. Lichterfeld M, Mou D, Cung TD, Williams KL, Waring MT, Huang J, Pereyra F, Trocha A, Freeman GJ, Rosenberg ES, Walker BD, Yu XG. Telomerase activity of HIV-1-specific CD8\+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors. Blood 2008;112:3679-3687.
35. Dagarag M, Evazyan T, Rao N, Effros RB. Genetic manipulation of telomerase in HIV-specific CD8 T cells: enhanced anti-viral functions accompany the increased proliferative potential and telomere stabilization. J Immunol 2004;173: 6303-6311. (Pubitemid 39487789)
36. Fauce SR, Jamieson BD, Chin AC, Mitsuyasu RT, Parish ST, Ng HL, Kitchen CM, Yang OO, Harley CB, Effros RB. Tel-omerase-based pharmacologic enhancement of antiviral function of human CD8\+ T lymphocytes. J Immunol 2008;181:7400-7406.
37. Pawelec G, Derhovanessian E, Larbi A, Strindhall J, Wikby A. Cytomegalovirus and human immunosenescence. Rev Med Virol 2009;19:47-56.
38. Dowd JB, Zajacova A, Aiello A. Early origins of health disparities: burden of infection, health, and socioeconomic status in U.S. children. Soc Sci Med 2009;68:699-707.
39. Kim NW, Wu F. Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol (TRAP). Nucleic Acids Res 1997;25:2595-2597. (Pubitemid 27298154)
40. Baerlocher GM, Vulto I, de Jong G, Lansdorp PM. Flow cytometry and FISH to measure the average length of telo-meres (flow FISH). Nat Protoc 2006;1:2365-2376.
41. Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 2009;37:e21.
42. Canela A, Vera E, Klatt P, Blasco MA. High-throughput telomere length quantification by FISH and its application to human population studies. Proc Natl Acad Sci USA 2007;104:5300-5305. (Pubitemid 47175675)
43. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994;91:9857-9860. (Pubitemid 24311907)
44. Rufer N, Brummendorf TH, Kolvraa S, Bischoff C, Chris-tensen K, Wadsworth L, Schulzer M, Lansdorp PM. Telo-mere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoi-etic stem cells and memory T cells in early childhood. J Exp Med 1999;190:157-167. (Pubitemid 29354909)
45. Frenck RW, Blackburn EH, Shannon KM. The rate of telo-mere sequence loss in human leukocytes varies with age. Proc Natl Acad Sci USA 1998;95:5607-5610. (Pubitemid 28224142)
46. Chidrawar S, Khan N, Wei W, McLarnon A, Smith N, Nayak L, Moss P. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin Exp Immunol 2009;155:423-432.
47. Hadrup SR, Strindhall J, Kollgaard T, Seremet T, Johansson B, Pawelec G, thor Straten P, Wikby A. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 2006;176:2645-2653. (Pubitemid 43201717)
48. Effros RB, Pawelec G. Replicative senescence of T cells: Does the hayflick limit lead to immune exhaustion? Immunol Today 1997;18:450-454. (Pubitemid 27381988)
49. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002;30.
50. Farzaneh-Far R, Lin J, Epel E, Lapham K, Blackburn E, Whooley MA. Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the heart and soul study. PLoS One 2010;5:e8612.
51. Brouilette SW, Whittaker A, Stevens SE, Van der Harst P, Goodall AH, Samani NJ. Telomere length is shorter in healthy offspring of subjects with coronary artery disease: Support for the telomere hypothesis. Heart 2008;94:422-425. (Pubitemid 351441394)
52. Van Der Harst P, Van Der Steege G, de Boer RA, Voors AA, Hall AS, Mulder MJ, Van Gilst WH, Van Veldhuisen DJ. Tomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol 2007;49:1459-1464. (Pubitemid 46482923)
53. Strindhall J, Nilsson BO, Lofgren S, Ernerudh J, Pawelec G, Johansson B, Wikby A. No Immune Risk Profile among individuals who reach 100 years of age: Findings from the Swedish NONA immune longitudinal study. Exp Gerontol 2007;42:753-761. (Pubitemid 47058867)
54. Effros RB, Dagarag M, Spaulding C, Man J. The role of CD8\+ T-cell replicative senescence in human aging. Immunol Rev 2005;205:147-157. (Pubitemid 40780183)
55. Gomez CR, Nomellini V, Faunce DE, Kovacs EJ. Innate immunity and aging. Exp Gerontol 2008;43:718-728.
56. Wenisch C, Patruta S, Daxbock F, Krause R, Horl W. Effect of age on human neutrophil function. J Leukoc Biol 2000;67:40-45. (Pubitemid 30046816)
57. Chatta GS, Andrews RG, Rodger E, Schrag M, Hammond WP, Dale DC. Hematopoietic progenitors and aging: alterations in granulocytic precursors and responsiveness to re-combinant human G-CSF, GM-CSF, and IL-3. J Gerontol 1993;48:M207-M212. (Pubitemid 23272452)
58. De Martinis M, Modesti M, Ginaldi L. Phenotypic and functional changes of circulating monocytes and polymor-phonuclear leucocytes from elderly persons. Immunol Cell Biol 2004;82:415-420. (Pubitemid 39141765)
59. Panda A, Arjona A, Sapey E, Bai F, Fikrig E, Montgomery RR, Lord JM, Shaw AC. Human innate immunosenescence: causes and consequences for immunity in old age. Trends Immunol 2009;30:325-333.
60. Solana R, Alonso MC, Pena J. Natural killer cells in healthy aging. Exp Gerontol 1999;34:435-443. (Pubitemid 29293621)
61. Mariani E, Meneghetti A, Formentini I, Neri S, Cattini L, Ravaglia G, Forti P, Facchini A. Different rates of telomere shortening and telomerase activity reduction in CD8 T and CD16 NK lymphocytes with ageing. Exp Gerontol 2003;38: 653-659. (Pubitemid 36694167)
62. Hemann M, Strong M, Hao L, Greider C. The shortest telo-mere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001;107:67-77. (Pubitemid 32972038)
63. Samper E, Flores J, Blasco M. Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc mice with short telomeres. EMBO reports 2001;2:800-807. (Pubitemid 32982748)
64. Teixeira MT, Arneric M, Sperisen P, Lingner J. Telomere length homeostasis is achieved via a switch between telo-merase- extendible and -nonextendible states. Cell 2004;117: 323-335. (Pubitemid 38534539)
65. Alter BP, Baerlocher GM, Savage SA, Chanock SJ, Weksler BB, Willner JP, Peters JA, Giri N, Lansdorp PM. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood 2007;110:1439-1447. (Pubitemid 47443958)